Degirmenci, E.; Sanli, O.; Kaytaz, M.; Kucukgergin, C.; Erdem, S.; Seckin, S.; Ozluk, Y.; Ozcan, F. ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates. J. Clin. Med. 2026, 15, 4182. https://doi.org/10.3390/jcm15114182

AMA Style

Degirmenci E, Sanli O, Kaytaz M, Kucukgergin C, Erdem S, Seckin S, Ozluk Y, Ozcan F. ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates. Journal of Clinical Medicine. 2026; 15(11):4182. https://doi.org/10.3390/jcm15114182

Chicago/Turabian Style

Degirmenci, Enes, Oner Sanli, Murat Kaytaz, Canan Kucukgergin, Selcuk Erdem, Sule Seckin, Yasemin Ozluk, and Faruk Ozcan. 2026. "ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates" Journal of Clinical Medicine 15, no. 11: 4182. https://doi.org/10.3390/jcm15114182

APA Style

Degirmenci, E., Sanli, O., Kaytaz, M., Kucukgergin, C., Erdem, S., Seckin, S., Ozluk, Y., & Ozcan, F. (2026). ZEB1-AS1 and miR-200b-3p Expression in Non-Muscle-Invasive Bladder Cancer: Pathological Correlates. Journal of Clinical Medicine, 15(11), 4182. https://doi.org/10.3390/jcm15114182

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI